The launch marks the first medical cannabis products Aphria RX has grown under the medical cannabis cultivation license ...
Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding ...
Medical, a division of Tilray Brands, announced the launch of its first commercial German grown medical cannabis flowers from its ...
On July 15, 2024, Tilray Medical was the first to receive a new cannabis cultivation license issued under MedCanG. This license allows Aphria RX to cultivate and manufacture a broad range of ...
With this trading license, Aphria RX is now able to sell and distribute medical cannabis products to a wide range of locations. That includes pharmacies, hospitals, and medical wholesalers in Germany.
Hosted on MSN3mon
German Cannabis Producer DEMECAN Becomes First Company To Receive Cultivation License Under Legalization Program, Sees Strong Revenue Growth (Updated)Canadian marijuana giant, Tilray Brands (NASDAQ:TLRY) also confirmed last week that its German cannabis cultivation facility, Aphria RX GmbH, has obtained the first new cannabis cultivation ...
Aphria Inc. was founded in 2013 when the leaders saw a future in cannabis and decided to apply more than 60 years of commercial agriculture and greenhouse expertise to grow a few medical cannabis ...
Tilray rallied as much as 27.2% on Wednesday after the company announced plans to merge with Aphria and create the world's biggest marijuana company. The two firms announced Wednesday they agreed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback